Dawei Yuan

1.0k total citations
49 papers, 750 citations indexed

About

Dawei Yuan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dawei Yuan has authored 49 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Dawei Yuan's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (8 papers) and Circular RNAs in diseases (6 papers). Dawei Yuan is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (8 papers) and Circular RNAs in diseases (6 papers). Dawei Yuan collaborates with scholars based in China, United States and Russia. Dawei Yuan's co-authors include Kun Zhu, Chengxue Dang, Rong Yan, Kang Li, Sasidhar Varanasi, Patricia Relue, Kang Li, Haonan Wang, Yong Jia and Yong Zhang and has published in prestigious journals such as Bioresource Technology, Scientific Reports and IEEE Access.

In The Last Decade

Dawei Yuan

47 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawei Yuan China 16 431 299 175 107 78 49 750
Yong Fang China 17 566 1.3× 269 0.9× 118 0.7× 171 1.6× 77 1.0× 50 953
Bin Luo China 16 406 0.9× 187 0.6× 154 0.9× 111 1.0× 100 1.3× 48 737
Dianbo Yao China 11 462 1.1× 177 0.6× 281 1.6× 120 1.1× 117 1.5× 20 892
Ningning Liu China 12 371 0.9× 202 0.7× 137 0.8× 66 0.6× 98 1.3× 22 588
Yanan Cheng China 13 372 0.9× 205 0.7× 87 0.5× 76 0.7× 59 0.8× 34 690
Dong Tang China 18 596 1.4× 192 0.6× 335 1.9× 106 1.0× 145 1.9× 70 1.0k
Bihua Lin China 15 429 1.0× 250 0.8× 188 1.1× 74 0.7× 131 1.7× 28 759

Countries citing papers authored by Dawei Yuan

Since Specialization
Citations

This map shows the geographic impact of Dawei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Yuan more than expected).

Fields of papers citing papers by Dawei Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Yuan. The network helps show where Dawei Yuan may publish in the future.

Co-authorship network of co-authors of Dawei Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Yuan. A scholar is included among the top collaborators of Dawei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Yuan. Dawei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Zhongxuan, Ruyi Zhang, Dawei Yuan, et al.. (2025). Association of branched-chain amino acids with major depressive disorder: A bidirectional Mendelian randomization study. Journal of Affective Disorders. 379. 467–472. 3 indexed citations
2.
Yuan, Dawei, et al.. (2024). Pre-classification-based multi-model fusion non-intrusive load identification. Journal of Computational Methods in Sciences and Engineering. 25(3). 2150–2158.
3.
Wang, Xueni, Yong Yang, Xin Xie, et al.. (2024). Chronic low-dose deltamethrin exposure induces colon injury and aggravates DSS-induced colitis via promoting cellular senescence. Ecotoxicology and Environmental Safety. 274. 116214–116214. 5 indexed citations
4.
An, Qi, Dawei Yuan, Jing‐Long Huang, et al.. (2024). Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia. Clinical Rheumatology. 43(5). 1491–1501. 4 indexed citations
5.
Zhang, Yunxiang, Xiangyu Guo, Chunsen Li, et al.. (2023). LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer. Molecular Cancer. 22(1). 41–41. 52 indexed citations
6.
Yuan, Dawei, Kun Zhu, Chengxue Dang, et al.. (2023). Factors affecting the ORR after neoadjuvant therapy of TP regimen combined with PD-1 inhibitors for esophageal cancer. Scientific Reports. 13(1). 6080–6080. 8 indexed citations
8.
Li, Kang, Gang Xu, Kun Zhu, et al.. (2021). Postoperative oxaliplatin-based hyperthermic intraperitoneal chemotherapy: an effective and safe palliative treatment option for colorectal cancer with peritoneal metastasis. World Journal of Surgical Oncology. 19(1). 200–200. 5 indexed citations
9.
Zhang, Hao, Xin Wang, Dawei Yuan, et al.. (2021). Patients’ Responses to the Sudden Interruption of Chemotherapy During the Outbreak of the Novel Coronavirus: A Cross-Sectional Study. Cancer Management and Research. Volume 13. 351–358. 8 indexed citations
10.
Zhang, Yunxiang, Yang Wang, Liquan Wang, et al.. (2021). Overexpression of LncRNA BM466146 Predicts Better Prognosis of Breast Cancer. Frontiers in Oncology. 10. 628757–628757. 15 indexed citations
11.
Meng, Lei, Rong Yan, Dawei Yuan, et al.. (2021). Profiles of immune infiltration in the tumor microenvironment of hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 12(3). 1152–1163. 6 indexed citations
12.
Yan, Na, et al.. (2020). A Review on Cancer of Unknown Primary Origin: The Role of Molecular Biomarkers in the Identification of Unknown Primary Origin. Methods in molecular biology. 2204. 109–119. 5 indexed citations
13.
Jiang, Zheng, Chunxiang Li, Zhixun Zhao, et al.. (2018). Abnormal Liver Function Induced by Space-Occupying Lesions Is Associated with Unfavorable Oncologic Outcome in Patients with Colorectal Cancer Liver Metastases. BioMed Research International. 2018. 1–7. 8 indexed citations
14.
Tong, Fangjia, Jingshu Geng, Bingqing Yan, et al.. (2018). Prevalence and Prognostic Significance of HPV in Laryngeal Squamous Cell Carcinoma in Northeast China. Cellular Physiology and Biochemistry. 49(1). 206–216. 22 indexed citations
15.
Yuan, Dawei, Rong Yan, Kang Li, et al.. (2015). [Small-cell neuroendocrine carcinoma of the stomach: a clinical and prognostic analysis of 21 cases].. PubMed. 37(3). 227–30. 1 indexed citations
16.
Yuan, Dawei, Kun Zhu, Chengxue Dang, et al.. (2014). NS5ATP9 mRNA levels in peripheral blood mononuclear cells predict prognosis in patients with gastric cancer. Medical Oncology. 31(8). 106–106. 4 indexed citations
17.
Cheng, Yao, Kang Li, Dongmei Diao, et al.. (2013). Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro. Laboratory Investigation. 93(12). 1276–1287. 38 indexed citations
18.
Zhu, Kun, Dongmei Diao, Chengxue Dang, et al.. (2012). Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer. Cancer Science. 104(3). 353–359. 35 indexed citations
19.
Yuan, Dawei, et al.. (2012). A viable method and configuration for fermenting biomass sugars to ethanol using native Saccharomyces cerevisiae. Bioresource Technology. 117. 92–98. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026